GlassScriptPhysician profile
Paul Lawrence Prendiville
NPI 1073507190
$2,767.44
in general payments reported to CMS, 2019-2025
21 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,143 · 2020: $193 · 2021: $248 · 2022: $163 · 2023: $350 · 2024: $293 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003 · Entertainment: $16.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.72 |
| Entertainment | $16.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,110.14 | 2019-2025 | Clareon, Argos, Hydrus Microstent |
| Allergan, INC. | $361.46 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $215.04 | 2019-2025 | Tecnis Simplicity |
| Amgen INC. | $200.89 | 2024-2025 | Tepezza |
| Glaukos Corporation | $126.02 | 2019 | |
| Abbvie INC. | $93.66 | 2022-2024 | |
| Thea Pharma INC. | $87.84 | 2023-2025 | Iyuzeh |
| Bausch & Lomb Americas INC. | $85.52 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Novartis Pharmaceuticals Corporation | $84.42 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $81.75 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $77.96 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $58.91 | 2019-2021 | |
| Biotissue Holdings INC. | $50.00 | 2024 | |
| Rxsight INC | $22.79 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
| Shire North American Group INC | $18.39 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $17.26 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Optos, INC. | $16.87 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Ocular Therapeutix, INC. | $15.15 | 2021 | |
| Beaver-Visitec International, INC. | $13.98 | 2021 | |
| Aerie Pharmaceuticals, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Prendiville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.